SCHEMBL9628933

SCHEMBL9628933

CC(=O)N(CC(N)=O)N1CCCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
LMNA P02545 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA3 P07451 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
CA5B Q9Y2D0 1/20 0.41
BRD4 O60885 1/20 0.33
BRD2 P25440 1/20 0.33
KMT2A Q03164 2/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9821185 0.94 TSHR (0.39) TSHRLMNACA12CA1CA2
SCHEMBL11242674 0.83 LMNA (0.40) TSHRLMNACA12CA1CA2
SCHEMBL11512589 0.81 KMT2A (0.39) TSHRLMNACA12CA1CA2
SCHEMBL9587421 0.80 LMNA (0.38) TSHRLMNACA12CA1CA2
SCHEMBL11513892 0.79 LMNA (0.36) TSHRLMNACA12CA1CA2
SCHEMBL11245719 0.79 LMNA (0.37) TSHRLMNACA12CA1CA2
SCHEMBL11512062 0.78 ALDH1A1 (0.38) LMNACA12CA1CA2CA3
SCHEMBL11513318 0.75 ALDH1A1 (0.40) KMT2ASMN1; SMN2
SCHEMBL11512525 0.74 HTT (0.56) TSHRLMNAKMT2ACHRM2CHRM4
SCHEMBL11514638 0.73 LMNA (0.43) TSHRLMNACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4162325-A PHARMACEUTICAL ACTIVITY ON THE MNEMIC PROCESSES UCB, SOCIETE ANONYME (BE) 1979-07-24 US claimed
EP-0207681-B1 PYRROLIDONE DERIVATIVES ISF SOCIETA PER AZIONI (IT) 1992-03-18 EP disclosed
EP-0243336-B1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INTERMITTENT CLAUDICATION U C B, S.A. (BE) 1990-06-13 EP disclosed
EP-0243336-A1 Pharmaceutical compositions for the treatment of intermittent claudication U C B, S.A. (BE) 1987-10-28 EP disclosed
US-4162325-A PHARMACEUTICAL ACTIVITY ON THE MNEMIC PROCESSES UCB, SOCIETE ANONYME (BE) 1979-07-24 US disclosed